Mark A. Socinski, MD - Assessing Maintenance Therapy in Advanced NSCLC: Is it True Maintenance or Exposure to Active Treatment?

In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the rationale for studying maintenance therapy in NSCLC settings and the clinical implications of new data on the maintenance use of active cytotoxic agents and targeted therapy in patients with advanced NSCLC.